well-said, . pfizer 2021 4th quarter earnings call today peppered with cancer as revenue growth, see example slides. five cancer-focused acquisitions during covid. complementary pivot with big revenues: small_orange_diamond 2020 $41.9b small_orange_diamond 2021 $81.3b small_orange_diamond 2022 $98-$102b guidance